Prostate Cancer - Results from #24380

The experience with cytotoxic chemotherapy in metastatic castration-resistant prostate cancer - Abstract November 16, 2012

Pathological features of lymph node metastases in predicting biochemical recurrence after radical prostatectomy for prostate cancer - Abstract November 16, 2012

The trifecta outcome in 300 consecutive cases of robotic-assisted laparoscopic radical prostatectomy according to D'Amico risk criteria - Abstract November 16, 2012

MAPPED study design: A 6 month randomised controlled study to evaluate the effect of dutasteride on prostate cancer volume using magnetic resonance imaging - Abstract November 16, 2012

Changes in quality of life among prostate cancer patients after surgery - Abstract November 16, 2012

Biology of castration-recurrent prostate cancer - Abstract November 15, 2012

Immunotherapy for castration-resistant prostate cancer - Abstract November 15, 2012

Moving toward personalized medicine in castration-resistant prostate cancer - Abstract November 15, 2012

Palliative care in castrate-resistant prostate cancer - Abstract November 15, 2012

Quality of life with advanced metastatic prostate cancer - Abstract November 15, 2012

The impact of abiraterone acetate therapy on patient-reported pain and functional status in chemotherapy-naive patients with progressive, metastatic castration-resistant prostate cancer - Lecture Presentation November 15, 2012

Natural history of early, localized prostate cancer: A final report from three decades of follow-up - Abstract November 15, 2012

Combination of diffusion-weighted magnetic resonance imaging and extended prostate biopsy predicts lobes without significant cancer: Application in patient selection for hemiablative focal therapy - Abstract November 15, 2012

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: Long-term results of a randomised controlled trial (EORTC trial 22911) - Abstract November 15, 2012

Robot-assisted radical prostatectomy: 5-Year oncological and biochemical outcomes - Abstract November 14, 2012

Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, despite no recommendations for PSA screening: Results from a population-based study, 2003-2011 - Abstract November 14, 2012

Readability of websites containing information about prostate cancer treatment options - Abstract November 14, 2012

Impact of androgen deprivation therapy on weight gain differs by age in men with nonmetastatic prostate cancer - Abstract November 14, 2012

Value of prostate specific antigen density and percent free prostate specific antigen for prostate cancer prognosis - Abstract November 14, 2012

Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer - Abstract November 14, 2012

Page 1220 of 1435